Pmv Pharmaceuticals Correlations

PMVP Stock

USD 1.61 0.04 2.55%

The current 90-days correlation between Pmv Pharmaceuticals and MediciNova is -0.2 (i.e., Good diversification). The correlation of Pmv Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Pmv Pharmaceuticals Correlation With Market

Significant diversification

The correlation between Pmv Pharmaceuticals and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Pmv Stock, please use our How to Invest in Pmv Pharmaceuticals guide.

Moving together with Pmv Stock

0.81	DRUG	Bright Minds Biosciences	Pair Corr
0.67	VRNA	Verona Pharma PLC	Pair Corr
0.68	VSTM	Verastem	Pair Corr

Moving against Pmv Stock

0.53	DOMH	Dominari Holdings	Pair Corr
0.47	DTIL	Precision BioSciences	Pair Corr
0.34	DRMA	Dermata Therapeutics	Pair Corr
0.33	DRTS	Alpha Tau Medical	Pair Corr
0.69	EDSA	Edesa Biotech Fiscal Year End 20th of December 2024	Pair Corr
0.6	VINC	Vincerx Pharma	Pair Corr
0.5	VXRT	Vaxart Inc	Pair Corr
0.43	VIRX	Viracta Therapeutics	Pair Corr
0.39	VRCA	Verrica Pharmaceuticals	Pair Corr
0.37	EDIT	Editas Medicine	Pair Corr

Related Correlations Analysis

	ELYM	MNOV	PHVS	PEPG	ANEB	ACRV	MOLN	MLYS	EWTX	RLYB
ELYM		0.09	-0.4	0.7	0.65	0.27	-0.29	-0.42	-0.69	0.61	ELYM
MNOV	0.09		-0.23	-0.11	0.0	-0.58	-0.48	-0.14	0.03	-0.01	MNOV
PHVS	-0.4	-0.23		-0.42	-0.18	0.13	0.36	0.42	0.54	-0.65	PHVS
PEPG	0.7	-0.11	-0.42		0.67	0.29	-0.29	-0.11	-0.47	0.77	PEPG
ANEB	0.65	0.0	-0.18	0.67		0.1	-0.37	-0.17	-0.27	0.48	ANEB
ACRV	0.27	-0.58	0.13	0.29	0.1		0.49	0.14	-0.26	0.37	ACRV
MOLN	-0.29	-0.48	0.36	-0.29	-0.37	0.49		0.11	-0.01	-0.22	MOLN
MLYS	-0.42	-0.14	0.42	-0.11	-0.17	0.14	0.11		0.77	-0.19	MLYS
EWTX	-0.69	0.03	0.54	-0.47	-0.27	-0.26	-0.01	0.77		-0.54	EWTX
RLYB	0.61	-0.01	-0.65	0.77	0.48	0.37	-0.22	-0.19	-0.54		RLYB
	ELYM	MNOV	PHVS	PEPG	ANEB	ACRV	MOLN	MLYS	EWTX	RLYB

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RLYB	+ 0.77	PEPG
EWTX	+ 0.77	MLYS
PEPG	+ 0.7	ELYM
ANEB	+ 0.67	PEPG
ANEB	+ 0.65	ELYM
RLYB	+ 0.61	ELYM

High negative correlations

EWTX	- 0.69	ELYM
RLYB	- 0.65	PHVS
ACRV	- 0.58	MNOV
RLYB	- 0.54	EWTX
MOLN	- 0.48	MNOV
EWTX	- 0.47	PEPG

Risk-Adjusted Indicators

There is a big difference between Pmv Stock performing well and Pmv Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pmv Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ELYM	3.96	(1.11)	0.00	(0.44)	0.00	0.00	6.21	(9.35)	34.87
MNOV	5.09	0.82	0.17	0.53	4.34	(7.23)	14.50	(8.50)	61.30
PHVS	2.78	0.33	0.04	(0.19)	3.02	(3.50)	7.76	(6.01)	21.41
PEPG	3.07	(0.97)	0.00	0.55	0.00	0.00	4.75	(9.02)	26.81
ANEB	5.08	(0.02)	0.00	0.16	0.00	0.00	8.61	(11.48)	76.00
ACRV	2.78	(0.56)	0.00	(1.45)	0.00	0.00	6.90	(7.65)	22.84
MOLN	4.73	(0.11)	(0.02)	0.00	5.15	(6.52)	9.61	(8.53)	52.92
MLYS	2.62	(0.08)	0.02	0.07	3.43	(2.63)	6.27	(5.79)	20.98
EWTX	3.63	0.57	0.21	0.30	3.05	(4.27)	6.65	(5.51)	61.02
RLYB	1.89	(0.20)	0.00	(1.97)	0.00	0.00	5.00	(4.35)	16.11

Pmv Pharmaceuticals Corporate Management

Laura Leon	VP Operations	Profile
Leila MD	Chief Officer	Profile
Winston MBA	COO CFO	Profile
Marc MD	Senior Affairs	Profile
Tim Smith	Senior Relations	Profile
Robert Ticktin	Head Counsel	Profile
Deepika PharmD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC